Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke "Urico-Ictus"

Completed

Phase 2/3 Results N/A

Summary of Purpose

The purpose of this study is to determine whether the combined treatment with Uric Acid and rtPA is superior to rtPA alone in terms of clinical efficacy in acute ischemic stroke patients treated within the first 4.5 hours of symptoms onset.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 March 2015.

1 Jun 2011 11 Mar 2009 1 Aug 2013 1 Oct 2013 1 Mar 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Angel Chamorro, MD, PhD.